✦ LIBER ✦

HBV-DNA, HBeAg/Anti-HBe Serological Status in Hepatitis B Chronic Individuals from Central Italy

✍ Scribed by M. Rapicetta, V. Di Nardo, C. Rozera, G. Marinucci, D. Francisci, B. Sarrecchia, C. Ricci and F. Albertoni

Book ID: 124444983
Publisher: Cambridge University Press
Year: 1990
Tongue: English
Weight: 824 KB
Volume: 104
Category: Article
ISSN: 0950-2688
DOI: 10.2307/3863382

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive value of ALT and HBV DNA leve

Predictive value of ALT and HBV DNA levels in response to sequential combination treatment of lamivudine and interferon in HBeAg—/ANTI-Hbe+ chronic hepatitis B

✍ Kubilay Cinar; Mustafa Sarioglu; Hulya Cetinkaya; Mithat Bozdayi; Ozden Uzunalim 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Defects in the precore region of the HBV

Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy

✍ Kiyoshi Takeda; Yoshihiro Akahane; Hiroshi Suzuki; Hiroaki Okamoto; Fumio Tsuda; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

Hepatitis B virus DNA clones were propagated from sera of six patients with chronic hepatitis B who seroconverted from HBeAg to antibody to HBeAg either spontaneously or after administration of Q- interferon. Defects in the precore region blocking synthesis and secretion of HBeAg were detected in al

421 A new bio-mathematical model to desc

421 A new bio-mathematical model to describe the dynamics of HBV-DNA and infected hepatocytes in HBEAG-negative/anti-HBE-positive chronic hepatitis B patients treated with peginterferon alfa-2A (40KD) (PEGASYS®), lamivudine, or PEGASYS® plus lamivudine combin

✍ P. Colombatto; R. Bizzarri; L. Civitano; F. Oliveri; F. Bonino; G. Germanidis; P 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB